Different patterns of Toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins

M Ioana1, B Ferwerda, T S Plantinga

  • 1Department of Internal Medicine, Radboud University Nijmegen Medical Centre, Radboud University, Nijmegen, Netherlands.

Infection and Immunity
|February 23, 2012
PubMed

Insights

Genetic variations in Toll-like receptor 2 (TLR2) differ across global populations. These TLR2 polymorphisms may explain variations in how different groups respond to microbial infections.

Area of Science:

  • Immunology
  • Genetics
  • Population Health

Background:

  • Innate immunity relies on pattern recognition receptors (PRRs) like Toll-like receptors (TLRs) to detect invading microorganisms.
  • Genetic variations within TLRs are known to influence an individual's susceptibility to infections.
  • TLR2 is a crucial TLR involved in pathogen recognition.

Purpose of the Study:

  • To investigate the genetic variation of TLR2 in diverse global populations.
  • To correlate observed TLR2 genetic variations with potential functional changes.
  • To understand how TLR2 polymorphisms might impact infection susceptibility across different ethnicities.

Main Methods:

  • Assessed three nonsynonymous TLR2 polymorphisms (1892C>A, 2029C>T, and 2258G>A).
  • Analyzed these polymorphisms in populations from Europe (Romanians, Vlax-Roma, Dutch), East Asia (Han Chinese), Africa (Dogon, Fulani), and America (Trio Indians).

Main Results:

  • The 2029C>T polymorphism was found primarily in Vlax-Roma, suggesting an Indo-Aryan origin post-migration to South Asia.
  • The 1892C>A polymorphism was exclusive to European populations, likely originating in proto-Indo-Europeans.
  • The 2258G>A polymorphism occurred at a low frequency, exclusively in European populations, including Vlax-Roma.

Conclusions:

  • The distinct distribution patterns of TLR2 polymorphisms across populations suggest a genetic basis for differential infection susceptibility.
  • These findings highlight the importance of population genetics in understanding immune response variations.
  • Further research can explore the functional consequences of these TLR2 variations on host defense mechanisms.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...